@KainCarver
Have a look at another long-suffering stem-cell company you are very familiar with on the ASX today.
+30% as I write.
Is it possible the trodden down bio-tech sector about to get some M&A activity? God knows there are some bargain companies out their for big Pharma still on their highs (I sold out of J&J too early).
I've just picked up a little more OCC from whoever just sold down again, but am getting overloaded vs my portfolio.
OCC Trading, page-999
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
62.0¢ |
Change
0.070(12.7%) |
Mkt cap ! $125.7M | |||
| Open | High | Low | Value | Volume |
| 56.5¢ | 62.0¢ | 56.5¢ | $627.2K | 1.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 20384 | 61.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.0¢ | 28837 | 2 |
View Market Depth
| Last trade - 11.00am 10/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |